These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 667880)
21. [Saralasin in resistant hypertensive crisis (author's transl)]. Röckel A; Heidland A Med Klin; 1979 Mar; 74(11):401-7. PubMed ID: 34782 [TBL] [Abstract][Full Text] [Related]
22. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril. Zawada ET; Stinson J; Ramirez G Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479 [TBL] [Abstract][Full Text] [Related]
23. [Angiotensin II inhibitors for the diagnosis and treatment of hypertension]. Brunner HR; Gavras H Schweiz Med Wochenschr; 1976 Dec; 106(50):1791-8. PubMed ID: 1013701 [TBL] [Abstract][Full Text] [Related]
24. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping. Bing RF; Russell GI; Swales JD; Thurston H J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368 [TBL] [Abstract][Full Text] [Related]
25. Angiotensin blockade in hypertension. Streeten DH; Anderson GH Ann Intern Med; 1977 Mar; 86(3):353-4. PubMed ID: 842997 [No Abstract] [Full Text] [Related]
26. [Clinical and experimental studies on the angiotensin inhibitor 1-sar-8-ile-angiotensin II (P 165)]. Werner U; Waelsch I; Bock KD Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1310-3. PubMed ID: 1029986 [No Abstract] [Full Text] [Related]
27. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration. Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166 [TBL] [Abstract][Full Text] [Related]
28. [Relation between the hypotensive and renin-stimulating effect of diuretic therapy in hypertensive patients]. Bianchini C; Sala C; Terzoli L; Sernesi L; Leonetti G; Zanchetti A Boll Soc Ital Cardiol; 1978; 23(10):1739-47. PubMed ID: 400389 [No Abstract] [Full Text] [Related]
29. Detection of renovascular hypertension with angiotensin II blockade. Baer L; Parra-Carrilo JZ; Radichevich I; Williams GS Ann Intern Med; 1977 Mar; 86(3):257-60. PubMed ID: 842983 [TBL] [Abstract][Full Text] [Related]
30. Physiologic studies with saralasin in animals. Gavras H; Gavras I; Brunner HR; Liang CS Kidney Int Suppl; 1979 Mar; (9):S20-8. PubMed ID: 384069 [No Abstract] [Full Text] [Related]
31. [Effects of saralasin on 20 hypertensive patients (author's transl)]. Plaza de los Reyes M; Passalacqua W; Plaza de los Reyes X; Pla C; Campino C Rev Med Chil; 1980 Feb; 108(2):115-20. PubMed ID: 7017869 [No Abstract] [Full Text] [Related]
32. The use of saralasin to evaluate the function of the brain renin-angiotensin system. Reid IA Prog Biochem Pharmacol; 1976; 12():117-34. PubMed ID: 1019160 [TBL] [Abstract][Full Text] [Related]
33. [Significance of renin-angiotensin system inhibitors in the diagnosis of hypertension]. Stumpe KO; Kolloch RE; Overlack A Med Welt; 1977 Oct; 28(41):1645-9. PubMed ID: 927124 [No Abstract] [Full Text] [Related]
34. Comparison of the biological effects of two angiotensin II analogues in hypertensive patients with sodium depletion. Hata T; Ogihara T; Mikami H; Nakamaru M; Maruyama A; Mandai T; Kumahara Y Life Sci; 1978 Jun; 22(21):1955-62. PubMed ID: 672437 [No Abstract] [Full Text] [Related]